<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">Hepatitis B is transmitted most commonly at birth from mother to baby, in early childhood, or sexually through blood and body fluid contact (
 <xref rid="bib4" ref-type="bibr">4</xref>, 
 <xref rid="bib5" ref-type="bibr">5</xref>). Without treatment, the cumulative incidence of liver cirrhosis over five years is around 10-20% in people with chronic active hepatitis B infection, and 2-5% of those with cirrhosis develop liver cancer each year (
 <xref rid="bib6" ref-type="bibr">6</xref>). Those infected at birth are at greater risk of disease progression to cirrhosis and liver cancer (
 <xref rid="bib7" ref-type="bibr">7</xref>). The rising global prevalence of the metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) coupled with hazardous alcohol consumption will likely increase liver-related mortality rates in people living with hepatitis B through accelerated progression of hepatitis B-related liver disease and liver cancer(8).
</p>
